Market Overview:
The global preclinical CRO market reached a value of US$ 4.6 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 8.2% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
A preclinical contract research organization (CRO) is a support center that provides expertise in research and development (R&D). It ensures that a medication or therapeutic gadget is sheltered and successfully developed before being launched in the market. It offers services that assist in clearing a pharmaceutical item through animal testing and advancing it to the clinical phase. Moreover, it provides critical studies to researchers, restorative workforce, different industries and legislative contacts for assessing drug efficacy and safety in animal models and completing Investigational New Drug (IND) filing studies.
The emerging trend of outsourcing represents one of the key factors impelling the market growth. Apart from this, preclinical CROs offer end-to-end services, such as toxicology testing, which is also contributing to the market growth. Furthermore, the market has witnessed a significant change in the process of drug approval by the Food and Drug Administration (FDA). The process now subjects the drug candidate to preclinical studies for establishing its safety and effectivity among humans before the approval. Besides this, the 21st Century Cures Act was passed by the United States Congress in 2016 to accelerate medical product development and fasten the approval process for the launch of medical devices and drugs. These initiatives are positively influencing the demand for preclinical CRO services. Other major factors, including the readily available skilled human resources, low cost of devices, and the increasing prevalence of chronic diseases, are anticipated to fuel the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global preclinical CRO market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on service and end use.
Breakup by Service:
- Bioanalysis and DMPK Studies
- Toxicology Testing
- Others
Breakup by End Use:
- Biopharmaceutical Companies
- Government and Academic Institutes
- Medical Device Companies
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Charles River Laboratories Inc., Covance Inc. (Laboratory Corporation of America Holdings), Eurofins Scientific, ICON Plc, MD Biosciences Inc. (MLM Medical Labs), Medpace, Parexel International Corporation, PPD Inc. and Wuxi AppTec.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2020 |
| Historical Period |
2015-2020 |
| Forecast Period |
2021-2026 |
| Units |
US$ Billion |
| Segment Coverage |
Service, End Use, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
Charles River Laboratories Inc., Covance Inc. (Laboratory Corporation of America Holdings), Eurofins Scientific, ICON Plc, MD Biosciences Inc. (MLM Medical Labs), Medpace, Parexel International Corporation, PPD Inc. and Wuxi AppTec |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global preclinical CRO market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global preclinical CRO market?
- What are the key regional markets?
- What is the breakup of the market based on the service?
- What is the breakup of the market based on the end use?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global preclinical CRO market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Preclinical CRO Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Service
6.1 Bioanalysis and DMPK Studies
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Toxicology Testing
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Others
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by End Use
7.1 Biopharmaceutical Companies
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Government and Academic Institutes
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Medical Device Companies
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Charles River Laboratories Inc.
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 Covance Inc. (Laboratory Corporation of America Holdings)
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 SWOT Analysis
13.3.3 Eurofins Scientific
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.4 ICON Plc
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.4.4 SWOT Analysis
13.3.5 MD Biosciences Inc. (MLM Medical Labs)
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.6 Medpace
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.6.4 SWOT Analysis
13.3.7 Parexel International Corporation
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 SWOT Analysis
13.3.8 PPD Inc.
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.8.4 SWOT Analysis
13.3.9 Wuxi AppTec
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
List of Figures
Figure 1: Global: Preclinical CRO Market: Major Drivers and Challenges
Figure 2: Global: Preclinical CRO Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Preclinical CRO Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Preclinical CRO Market: Breakup by Service (in %), 2020
Figure 5: Global: Preclinical CRO Market: Breakup by End Use (in %), 2020
Figure 6: Global: Preclinical CRO Market: Breakup by Region (in %), 2020
Figure 7: Global: Preclinical CRO (Bioanalysis and DMPK Studies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 8: Global: Preclinical CRO (Bioanalysis and DMPK Studies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 9: Global: Preclinical CRO (Toxicology Testing) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Global: Preclinical CRO (Toxicology Testing) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Global: Preclinical CRO (Other Services) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Preclinical CRO (Other Services) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Preclinical CRO (Biopharmaceutical Companies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Preclinical CRO (Biopharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Preclinical CRO (Government and Academic Institutes) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Preclinical CRO (Government and Academic Institutes) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Preclinical CRO (Medical Device Companies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Global: Preclinical CRO (Medical Device Companies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: North America: Preclinical CRO Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: North America: Preclinical CRO Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: United States: Preclinical CRO Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: United States: Preclinical CRO Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Canada: Preclinical CRO Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Canada: Preclinical CRO Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Asia-Pacific: Preclinical CRO Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Asia-Pacific: Preclinical CRO Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: China: Preclinical CRO Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: China: Preclinical CRO Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: Japan: Preclinical CRO Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: Japan: Preclinical CRO Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: India: Preclinical CRO Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: India: Preclinical CRO Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: South Korea: Preclinical CRO Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: South Korea: Preclinical CRO Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Australia: Preclinical CRO Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Australia: Preclinical CRO Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: Indonesia: Preclinical CRO Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: Indonesia: Preclinical CRO Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: Others: Preclinical CRO Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: Others: Preclinical CRO Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: Europe: Preclinical CRO Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: Europe: Preclinical CRO Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: Germany: Preclinical CRO Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: Germany: Preclinical CRO Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: France: Preclinical CRO Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: France: Preclinical CRO Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: United Kingdom: Preclinical CRO Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: United Kingdom: Preclinical CRO Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: Italy: Preclinical CRO Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: Italy: Preclinical CRO Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: Spain: Preclinical CRO Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: Spain: Preclinical CRO Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: Russia: Preclinical CRO Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: Russia: Preclinical CRO Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: Others: Preclinical CRO Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: Others: Preclinical CRO Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: Latin America: Preclinical CRO Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: Latin America: Preclinical CRO Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: Brazil: Preclinical CRO Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: Brazil: Preclinical CRO Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: Mexico: Preclinical CRO Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: Mexico: Preclinical CRO Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: Others: Preclinical CRO Market: Sales Value (in Million US$), 2015 & 2020
Figure 64: Others: Preclinical CRO Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 65: Middle East and Africa: Preclinical CRO Market: Sales Value (in Million US$), 2015 & 2020
Figure 66: Middle East and Africa: Preclinical CRO Market: Breakup by Country (in %), 2020
Figure 67: Middle East and Africa: Preclinical CRO Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Global: Preclinical CRO Industry: SWOT Analysis
Figure 69: Global: Preclinical CRO Industry: Value Chain Analysis
Figure 70: Global: Preclinical CRO Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Preclinical CRO Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Preclinical CRO Market Forecast: Breakup by Service (in Million US$), 2021-2026
Table 3: Global: Preclinical CRO Market Forecast: Breakup by End Use (in Million US$), 2021-2026
Table 4: Global: Preclinical CRO Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 5: Global: Preclinical CRO Market: Competitive Structure
Table 6: Global: Preclinical CRO Market: Key Players